References
- Kaye AD, Okeagu CN, Pham AD, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol. 2021;35(3):293–306.
- The impact of COVID-19 on health and health systems [Internet]. OECD. 2022 cited 2022 Jul 24]. Available from 2022 Jul 24: https://www.oecd.org/health/covid-19.htm.
- Coronavirus (COVID-19) Dashboard [Internet]. World Health Organization. 2022 cited 2022 Jul 24]. Available from 2022 Jul 24: https://covid19.who.int/.
- Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324(15):1495–1496.
- Bartsch SM, Ferguson MC, McKinnell JA, et al. The potential health care costs and resource use associated with COVID-19 in the United States. Health Affairs. 2020;39(6):927–935.
- Gaunt ER, Harvala H, McIntyre C, et al. Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol. 2011;52(3):215–221.
- Murray CJL, Lopez AD, World Health O, et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary/edited. 1996. Murray CJL, Lopez AD. Geneva: World Health Organization
- Kempler C How covid-19 mitigation measures disproportionately impacted women and girls 2022 [Internet]. Johns Hopkins Bloomberg School of Public Health. 2022 cited 2022 Jul 23]. Available from 2022 Jul 23: https://publichealth.jhu.edu/2022/covid-19-shutdowns-disproportionately-harmed-women.
- COVID-19 response health equity strategy: accelerating progress towards reducing covid-19 disparities and achieving health equity 2022 [Internet]. Centers for Disease Control and Prevention (CDC). 2022 cited 2022 Jun 20]. Available from 2022 Jun 20: https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/cdc-strategy.html.
- Coronavirus Pandemic (COVID-19) [Internet]. Our World In Data. 2022 cited 2022 Apr 22]. Available from 2022 Apr 22: https://ourworldindata.org/coronavirus.
- Bell E, Brassel S, Oliver E, et al. Estimates of the global burden of COVID-19 and the value of broad and equitable access to COVID-19 vaccines. Vaccines (Basel). 2022;10(8):1320.
- Di Fusco M, Marczell K, Deger KA, et al., Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. J Med Econ. 2022. 25(1): 605–617.
- Steele MK, Couture A, Reed C, et al., Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021. JAMA Network Open. 2022. 5(7): e2220385–e.
- Sacco C, Mateo-Urdiales A, Petrone D, et al. Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021. Euro surveillance. 2021. 26(47): 2101001.
- Arbel R, Moore CM, Sergienko R, et al. How many lives do COVID vaccines save? Evidence from Israel. Am J Infect Control. 2022;50(3):258–261.
- Li Z, Liu X, Liu M, et al. The effect of the COVID-19 vaccine on daily cases and deaths based on global vaccine data. Vaccines (Basel). 2021;9(11):1328.
- Watson OJ, Barnsley G, Toor J, et al., Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022. 22(9): 1293–1302.
- Chapman R, Sutton K, Dillon-Murphy D, et al. Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: a modelling analysis. Vaccine. 2020;38(45):7138–7145.
- Impact of COVID-19 vaccines on mortality in England: December 2020 to March 2021 [Internet]. Public Health of England. 2021 cited 2022 Jun 2]. Available from 2022 Jun 2: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977249/PHE_COVID-19_vaccine_impact_on_mortality_March.pdf
- Scott A, Chambers R, Reimbaeva M, et al. Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States. J Med Econ. 2022;25(1):287–298.
- Ohsfeldt RL, Choong CK, Mc Collam PL, et al. Inpatient hospital costs for COVID-19 patients in the United States. Adv Ther. 2021;38(11):5557–5595.
- Yeates EO, Nahmias J, Chinn J, et al. Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure. PLOS ONE. 2021;16(6):e0253767.
- Patone M, Thomas K, Hatch R, et al. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study. Lancet Infect Dis. 2021;21(11):1518–1528.
- Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275–1287.
- Faramarzi A, Javan-Noughabi J, Tabatabaee SS, et al. The lost productivity cost of absenteeism due to COVID-19 in health care workers in Iran: a case study in the hospitals of mashhad university of medical sciences. BMC Health Serv Res. 2021;21(1):1169.
- Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). The World Health Organization. 2020. . cited 2022 Nov 28]. Available from 2022 Nov 28: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
- COVID-19 vaccine tracker [internet]. VIPER group COVID19 vaccine tracker. 2022 [cited 2022, May 31]. Available from 2022 May 31: https://covid19.trackvaccines.org/.
- COVID-19 vaccine efficacy summary [internet]. The institute for health metrics and evaluation (IHME). 2022 [cited 2022 Jun 1]. Available from 2022 Jun 1: https://www.healthdata.org/covid/covid-19-vaccine-efficacy-summary.
- Barasa E, Kairu A, Ng’ang’a W, et al. Examining unit costs for COVID-19 case management in Kenya. BMJ Glob Health. 2021;6(4):e004159.
- Ismaila H, Asamani JA, Lokossou VK, et al. The cost of clinical management of SARS-COV-2 (COVID-19) infection by level of disease severity in Ghana: a protocol-based cost of illness analysis. BMC Health Serv Res. 2021;21(1):1115.
- Jin H, Wang H, Li X, et al. Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study. Bull World Health Organ. 2021;99(2):112–124.
- López-Valcárcel BG, Vallejo-Torres L. The costs of COVID-19 and the cost-effectiveness of testing. Appl Econ. 2021;29(85):77–89.
- Maltezou HC, Giannouchos TV, Pavli A, et al. Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis. J Hosp Infect. 2021;114:126–133.
- Nakhaei K, Jalilian H, Arab-Zozani M, et al. Direct and indirect cost of COVID-19 patients in Iran. Health Policy Technol. 2021;10(4):100572.
- Tsai Y, Vogt TM, Zhou F. Patient characteristics and costs associated with COVID-19-related medical care among medicare fee-for-service beneficiaries. Ann Intern Med. 2021;174(8):1101–1109.
- WHO-CHOICE estimates of cost for inpatient and outpatient health service delivery 2021 [Internet]. World Health Organization (WHO). 2008 cited 2022 Jun 10]. Available from 2022 Jun 10: https://www.who.int/publications/m/item/who-choice-estimates-of-cost-for-inpatient-and-outpatient-health-service-delivery.
- Statistics USBoL - consumer price index [Internet]. US Bureau of Labor Statistics. 2022 cited 2022 Jul 1]. Available from 2022 Jul 1: https://www.bls.gov/cpi/.
- Labor Force Participation Rates [Internet]. World Bank. 2022 cited 2022 Jun 27]. Available from 2022 Jun 27: https://data.worldbank.org/indicator/SL.TLF.CACT.ZS.
- GNI per capita, atlas method (current US$) [Internet]. World Bank. 2022 cited 2022 Jun 27]. Available from 2022 Jun 27: https://data.worldbank.org/indicator/NY.GNP.PCAP.CD.
- Rahmandad H, Lim TY, Sterman J. Behavioral dynamics of COVID-19: estimating underreporting, multiple waves, and adherence fatigue across 92 nations. Syst Dyn Rev. 2021;37(1):5–31.
- Lau H, Khosrawipour T, Kocbach P, et al. Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters. Pulmonology. 2021;27(2):110–115.
- COVID-19 vaccine doses administered by manufacturer [Internet]. Our World in Data. 2022 cited 2022 Jun 15. Available from: https://ourworldindata.org/grapher/covid-vaccine-doses-by-manufacturer?country=~European+Union.
- Tan ST, Park HJ, Rodríguez-Barraquer I, et al. COVID-19 vaccination and estimated public health impact in California. JAMA Network Open. 2022;5(4):e228526–e.
- Vilches TN, Moghadas SM, Sah P, et al. Estimating COVID-19 infections, hospitalizations, and deaths following the US vaccination campaigns during the pandemic. JAMA Network Open. 2022;5(1):e2142725–e.
- Eyre DW, Taylor D, Purver M, et al. Effect of covid-19 vaccination on transmission of alpha and delta variants. N Engl J Med. 2022;386(8):744–756.
- Kohli M, Maschio M, Becker D, et al. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization. Vaccine. 2021;39(7):1157–1164.
- Sandmann FG, Davies NG, Vassall A, et al. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Lancet Infect Dis. 2021;21(7):962–974.
- Reddy KP, Fitzmaurice KP, Scott JA, et al. Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa. Nat Commun. 2021;12(1):6238.
- Wang WC, Fann JC, Chang RE, et al. Economic evaluation for mass vaccination against COVID-19. J Formos Med Assoc. 2021;120 Suppl 1:S95–s105.
- Vaezi A, Meysamie A. COVID-19 vaccines cost-effectiveness analysis: a scenario for Iran. Vaccines (Basel). 2021;10(1). 10.3390/vaccines10010037
- Calderón-Moreno J, Juárez-Vela R, Delgado-Rodríguez MJ, et al. Approximation to the consumption of healthcare resources and the economic cost of SARS-CoV-2 patient management: a retrospective study. Front Public Health. 2022;10:843751.
- Thant PW, Htet KT, Win WY, et al. Cost estimates of COVID-19 clinical management in Myanmar. BMC Health Serv Res. 2021;21(1):1365.
- Stenberg K, Lauer JA, Gkountouras G, et al. Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery. Cost Eff Resour Alloc. 2018;16(1):11.
- Zhang S, Incardona B, Qazi SA, et al. Cost-effectiveness analysis of revised WHO guidelines for management of childhood pneumonia in 74 Countdown countries. J Glob Health. 2017;7(1):010409.
- Wang F, Wang JD. Estimating US earnings loss associated with COVID-19 based on human capital calculation. Int J Environ Res Public Health. 2022;19(2):1015.
- Nurchis MC, Pascucci D, Sapienza M, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12). 10.3390/ijerph17124233.
- Debrabant K, Grønbæk L, Kronborg C. The cost-effectiveness of a COVID-19 vaccine in a Danish context. Clin Drug Investig. 2021;41(11):975–988.
- Bai W, Sha S, Cheung T, et al. Optimizing the dynamic zero-COVID policy in China. Int J Biol Sci. 2022;18(14):5314–5316.
- Özüdoğru O, Bahçe YG, Acer Ö. 2022. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants. Ir J Med Sci. 1971. 10.1007/s11845-022-03060-4.
- Kirson N, Swallow E, Lu J, et al. The societal economic value of COVID-19 vaccines in the United S tates. J Med Econ. 2022;25(1):119–128.
- Kutasi K, Koltai J, Szabó-Morvai Á, et al. Understanding hesitancy with revealed preferences across COVID-19 vaccine types. Sci Rep. 2022;12(1):13293.